Life Sciences Veteran to Lead Commercialization of Disruptive Digital PCR Technology for a Broad Range of Basic Research and Clinical Applications BOSTON & PARIS — Stilla Technologies, the company innovating the next generation of digital PCR solutions for life science research and clinical diagnostics, today announced the appointment of Matthew Grow, PhD, to Vice President […]

— Accelerates Conversion from Microarray to Genotyping by Sequencing– — Expands NGS Capabilities into New Markets — SOUTH SAN FRANCISCO, Calif. —  Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the acquisition of iGenomX, a company offering multiplex library […]

HELSINKI, Finland —  Euformatics, a bioinformatics software company providing world-leading NGS interpretation and quality control tools has signed a distribution agreement with INSVAST, a company specialising in delivering bioinformatics solutions to Chinese NGS laboratories. The agreement covers the full omnomics Suite of products from Euformatics and provides INSVAST with a full end-to-end offering to their customers […]

Company plans to work with multiple microscope partners to broaden access to the CODEX® solution for single-cell, multiplexed imaging MARLBOROUGH, Mass. — Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, today announced partnerships with premier microscope providers, Nikon, CrestOptics, and Andor to enable the development of new spatial biology applications, through the recently announced […]

Porvair Sciences has further expanded its range of high-performance microplate products for SARS-CoV-2 nucleic acid purification. The new KF deep well plate and tip comb plate combo are specifically designed to enhance the performance and productivity of the market-leading Thermo Scientific™ KingFisher™ range of nucleic acid purification systems. Krzysztof Kielmann, microplates product manager at Porvair Sciences commented “The Kingfisher Flex […]

Next generation organ-on-a-chip (OOC) technology to be used to investigate the human gut microbiome for improving outcomes for patients with liver cirrhosis Adoption follows successful collaboration demonstrating value of PhysioMimix’s ability to recapitulate physiological functions of the human intestinal villi Cambridge and London, UK: CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single […]

Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the close of a $276 million Series C financing. New investors Janus Henderson Investors, Logos Capital, Meritech Capital Partners, Counterpoint Global (Morgan Stanley), and T. Rowe Price joined existing investors Fidelity Management & Research Company, Foresite Capital, JS Capital Management LLC, RA Capital Advisors, and Venrock. With this latest investment, Element Biosciences […]

Combined with Cytiva’s existing manufacturing in Logan, Utah, Intermountain will boost global production of buffers and liquid cell culture media to Cytiva’s customers Responds to increased demand for products that are used in emerging modalities such as gene therapy, and are currently in high demand for the manufacture of COVID-19 vaccines and therapies Cytiva intends […]

The collaboration will empower human identification laboratories with superior tools and support needed to deliver more impactful outcomes. SAN DIEGO, Calif. & HILDEN, Germany & GERMAN TOWN, Md. – QIAGEN N.V. (NYSE: QGEN) (Frankfurt Prime Standard: QIA) and Verogen Inc. today announced a partnership to provide laboratories with superior tools and comprehensive support for implementing next-generation […]

QIAGEN increases forensics market lead with solutions from sample collection to identification Collaboration will provide customers workflow tools and support for highest quality outcomes Verogen broadens reach of sequencing and analysis products for forensic and human identity samples GERMANTOWN, Md. & HILDEN, Germany — QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a […]